Collectively, these observations indicate that FMF functions as a systemic inflammatory state capable of influencing the onset, course, and clinical expression of a variety of autoimmune and metabolic disorders, with the magnitude and direction of these interactions dependent on disease-specific pathophysiology. The gene discussed is MEFV; the disease is metabolic disease.